Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Pancreas. 2013 Apr;42(3):411–421. doi: 10.1097/MPA.0b013e31826cb243

Figure 1.

Figure 1

Immunohistochemical analysis of pancreatic endocrine tumors. Panels illustrate individual PET specimens in the TMA (original magnification × 200) exhibiting strong immunostaining for (A) VEGFR1, (B) TGFBR1, (C) PDGFRA, (D) SSTR5, (E) SSTR2A, (F) IGF1R, (G) Hsp90, (H) EGFR, (I) mTOR, and (J) MGMT.